SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.240-1.2%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: RoadyHD12/14/2019 12:15:52 PM
  Read Replies (3) of 12873
 
Unsurprisingly, the ill-advised 150mm SA failed. Given the dire capital deficiency and basement-level market cap, this will be a wake up call to Dr Diwan. Hopefully he will heed it. He will soon have to hold a special shareholder meeting for a sensible SA (20-30mm shares). He will also have to attract an equity underwriter for a feasible $10mm stop gap raise to get us through Phase 1, which means not only that sensible SA but also conversion of any bridge loan disbursements into equity and perhaps also even rationalized licensing terms with TheraCour. I just don't see them getting $10mm from professional equity investors without these. It's do or die here now with the publicly traded entity NNVC, the capital raising vehicle.

NNVC's licensing deals with TheraCour would be acceptable and reasonably attractive if NNVC were a BP (hence the supposed "fair" opinions) with lots of cash and capital and a distribution channel. But it is not. This is why DD is losing directors and executives and is finding itself unable to attract capital. NNVC itself is simply not an attractive investment vehicle. Hence the $100mm shareholder capital deficit with a market cap of only $7mm and no willing backers.

So let's see if DD heeds this wake up call. I'm looking for the announcement of a new, reasonable SA vote that also includes a change in bridge loan terms (to convertibility) and pursuit of a bigger capital raise that includes milestone disbursements. I do believe this is what he is hearing from underwriters who have been balking and are no doubt now telling DD about these necessary changes. And this stuff needs to happen in the next two months. DD know this.

If we do hear this, the stock will jump enormously, because the market would be interested in funding NNVC under such terms.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext